Extra-intestinal Applications of Fecal Microbiota Transplantation: Volume One: Foundations and Applications in Metabolic, Respiratory, Hormonal, and Dermatological Diseases provides real world applications of Fecal Microbiota Transplantation (FMT) in various metabolic, respiratory, hormonal, and dermatological disease pathologies. The content provides a comprehensive view of FMT beyond intestinal pathologies, including content on extra-intestinal applications of FMT and lesser-known concepts of gut brain axis, gut lung axis, gut skin axis and gut vagina bladder axis. Content coverage also includes a comparison of regulatory guidelines for FMT in various countries and various routes of administration of FMT with advantages and limitations. This is the perfect reference for researchers involved in work on bacteriotherapeutics as it provides a comprehensive view of the extra-intestinal applications of FMT while discussing the lesser known concepts of the gut axis.
Les mer
1. Bacteriotherapy 2. Fecal Microbiota Transplant- Historical perspective and contemporary application 3. Lab Techniques in Microbiome Research Application of FMT in metabolic diseases 4. FMT in diabetes and its co-morbidities 5. FMT in obesity 6. FMT in severe alcoholic hepatitis 7. FMT in osteoporosis Application of FMT in respiratory diseases 8. FMT in respiratory infections 9. FMT in cystic fibrosis 10. FMT in asthma 11. FMT in polycystic ovarian syndrome 12. FMT in endometriosis 13. FMT in reproductive carcinomas Application of FMT in dermatological diseases 14. FMT in atopic dermatitis 15. FMT in psoriasis 16. FMT in melanomas 17. FMT in alopecia 18. FMT in graft versus host diseases
Les mer
Provides a comprehensive overview of fecal microbiota transplantation in various metabolic, respiratory, hormonal, and dermatological disease pathologies
Discusses the applications of FMT in various metabolic, respiratory, hormonal, and dermatological disease pathologies Provides coverage from basic concepts to clinical applications, along with associated regulatory issues Elucidates pragmatic and forthcoming options like sterile fecal filtrate and bacterial consortia
Les mer

Produktdetaljer

ISBN
9780443153259
Publisert
2026-02-01
Utgiver
Elsevier Science Publishing Co Inc; Academic Press Inc
Høyde
235 mm
Bredde
191 mm
Aldersnivå
UP, 05
Språk
Product language
Engelsk
Format
Product format
Heftet
Antall sider
350

Om bidragsyterne

Dr Monica Gulati is the Registrar and Sr. Dean at the School of Pharmaceutical Sciences, Lovely Professional University with more than 25 years of teaching, industry, research and administrative experience. Her research forte is enhancing bio-performance of drug molecules including small and large biomolecules, phytochemicals and probiotics, metabiotics and other biotherapeutics using conventional and novel dosage forms especially in the area of colon targeting. She holds a keen interest in the quality control parameters of delivery systems. Her group has designed novel platform technologies to overcome challenges in therapeutic delivery of different classes of phyto-polypeptides and phytochemicals. She has more than 125 high impact publications and 15 invited book chapters to her credit, with an H-index of 26 and RG score of 38.3. She has been granted two Indian patents and three Australian patents while eighteen more have been filed and published. She is on the Editorial and Review Board of more than 25 journals. Dr. Sachin Kumar Singh, is working as professor and head of Pharmaceutical Chemistry and Quality Assurance at School of Pharmaceutical Sciences, Lovely Professional University, India. He is an honorary professor at Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), School of Public Health, University of Technology Sydney, Australia and School of Medical and Life Sciences, Sunway University, 47500 Sunway City, Malaysia. He has 14 years of teaching and research experience. Dr. Singh has completed one DST-SERB funded project on development of SNEDDS of Polypeptide-k for treatment of diabetes mellitus. He has published 500 plus research papers with cumulative impact of 1500 plus, authored 5 books and 25 book chapters. He has 10 granted patents to his credit. He is expert in development of novel drug delivery systems, synbiotics based formulations, analytical and bioanalytical method development and BA-BE studies. He has graduated 17 PhD students and 35 M Pharmacy students and currently graduating 3 masters and 6 PhD students. He is also featured under top 2% scientists of world as per the list of 2021, 2022 and 2023, published by Stanford University, USA. Currently his “h” index is 48 with 11000 plus citations. He is a recipient various national awards including Dr. B.C. Deb memorial award for popularization of science-2020 (honoured by Indian Science Congress Association), Bharat Shiksha Ratan Award-2014 (by Global Society for Health and Educational Growth, Delhi, India) and Bharat Gaurav Puraskar-2022 (by KTK outstanding achievers and education foundation, New Delhi) and Distinguished Alumnus Award (by Sree Siddaganga College of Pharmacy, Tumakuru, Karnataka). Dr. Bhupinder Kapoor is presently working as Associate Professor at School of Pharmaceutical Sciences, Lovely Professional University, India. Dr. Kapoor earned his doctoral degree in Pharmaceutical Sciences from Lovely Professional University, Punjab, India. With an expertise in the physic-chemical and physic-mechanical properties of vesicular and complex delivery systems, he has authored more than 40 international publications in well reputed peer-reviewed journals including book chapters. He is on the rewire board of a number of high impact journals. His current research focuses on drug delivery and targeting, nanomedicine, and nutraceuticals.